Background illustration for clinical trials search

Paid Clinical Trials Rockville

Discover 2,411 paid clinical trials in Rockville, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

for
Urothelial Cancer
Location: Washington D.C. DC, Baltimore MD, Charlottesville VA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07106762

Phase2, Phase3, Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

for
Advanced Renal Cell Carcinoma (RCC)
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07293351

Phase1, Phase2, Recruiting

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

for
Bladder Cancer
Location: Washington D.C. DC, Baltimore MD, Norfolk VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07419295

Phase3, Recruiting

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

for
Familial Adenomatous Polyposis (FAP)
Location: Washington D.C. DC, Baltimore MD, Danville PA,
Sponsor: Rapamycin Holdings Inc.

Sex: All

Age: 18+

Code: NCT06950385

Phase3, Recruiting

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer,
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07421700

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Washington D.C. DC, Baltimore MD, Elkton MD, Newark DE,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase3, Recruiting

Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy

for
Bladder Cancer
Location: Washington D.C. DC, Baltimore MD
Sponsor: Johns Hopkins University

Sex: Male

Age: 18+

Code: NCT05792722

Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute,
Location: Baltimore MD, Fairfax VA, Charlottesville VA,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 12+

Code: NCT04988555

Phase1, Phase2, Recruiting

The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer

for
Breast Cancer, Insomnia, Weight Gain
Location: Washington D.C. DC, Baltimore MD, Lutherville MD
Sponsor: Johns Hopkins University

Sex: Female

Age: 18+

Code: NCT05780814

Recruiting

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

for
Crohn's Disease, Ulcerative Colitis
Location: Glen Burnie MD, Tyler TX
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06764615

Phase2, Recruiting

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Washington D.C. DC, Fairfax VA, Leesburg VA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06500481

Phase3, Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: Baltimore MD, Lancaster PA, Bala-Cynwyd PA,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase2, Recruiting

Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients

for
Brain Tumor, Head and Neck Cancer
Location: Washington D.C. DC, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 1 - 26

Code: NCT05658731

Recruiting

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Washington D.C. DC, Baltimore MD, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05896839

Phase1, Phase2, Recruiting

Prospective Study to Assess a Diagnostic Aid for Cancer

for
Cancer
Location: Annapolis MD, York PA, Harrisburg PA, Wyomissing PA,
Sponsor: Harbinger Health

Sex: All

Age: 45+

Code: NCT07046260

Recruiting

Optimizing Dimensions of Reinforcement

for
Intellectual Disabilities (F70-F79), Autism
Location: Baltimore MD, Rochester Hills MI, Auburn AL
Sponsor: Auburn University

Sex: All

Age: 6 - 17

Code: NCT07137273

Recruiting

Renal Retention in High Grade Upper Tract Urothelial Cancer

for
High Grade Urothelial Carcinoma, Bladder Cancer,
Location: Washington D.C. DC, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT05656235

Phase2, Recruiting

Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old

for
Shigella
Location: Baltimore MD
Sponsor: Eveliqure Biotechnologies GmbH

Sex: All

Age: 18 - 50

Code: NCT07049159

Phase2, Recruiting

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

for
Metastatic Sarcoma, Radiation Therapy Patient, Ewing Sarcoma,
Location: Washington D.C. DC, Baltimore MD, Minneapolis MN
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 0 - 39

Code: NCT06796543

Recruiting

Early Achievements - Shaping Early Language and Literacy Skills

for
Developmental Language Disorder
Location: Baltimore MD
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Sex: All

Age: 3 - 5

Code: NCT07103044

Recruiting